Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer. Duchesneau ED, An SJ, Strassle PD, Reeder-Hayes KE, et al. Ann Surg Oncol 2022 Jan 17. pii: 10.1245/s10434-021-11260.

Read + Share

Amedeo Smart

Independent Medical Education

Duchesneau ED, An SJ, Strassle PD, Reeder-Hayes KE, et al. Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer. Ann Surg Oncol 2022 Jan 17. pii: 10.1245/s10434-021-11260.
PMID: 35039947